Emerging Markets Earnings Roundup: Abbott, AbbVie, J&J, GSK (Part 3)

After Abbott/AbbVie split, emerging markets represent 40% of Abbott’s sales compared to 15% of AbbVie sales. Abbott, J&J and GSK report dismal sales in Europe, noting that EMs remain a bright spot.